illumicell AI Raises $2M Pre-Seed to Launch Real-Time AI Platform for Male Fertility Diagnostics
Summary
BOSTON, April 10, 2025 /PRNewswire/ -- Techmed startup , founded by Harvard-trained physician Michel Bielecki, former McKinsey consultant Jeyla Sadikova, and rocket engineer Loup Cordey, has raised $2M in pre-seed funding to accelerate development of the first portable "lab scanner" and real-time AI platform for fluid-based diagnostics, capable of analyzing cells and biomarkers within minutes. illumicell AI aims to redefine male fertility care and unlock a broader infrastructure for cellular health data.Investors include top-tier healthcare operators, clinicians, and early-stage funds such as KOFA Healthcare, Harvard Phoenix Venture Fund, and MedTechSyndicates.While 1 in 6 couples face infertility, under 25% of men receive proper evaluation. "Up to half of all cases of infertility involve male factors, but the fertility burden remains almost entirely on women: a bias thats both culturally driven and scientifically flawed," said co-founder & CSO Jeyla Sadikova. "Our real-time, lab-grade fluid diagnostics reduce wait times and cost, radically improving the quality of healthcare across the board. As early clinical trials already outperform legacy systems, FDA submission is planned for 2026.illumicell AI has been selected by innovation programs including Harvard i-Labs, Creative Destruction Lab, MassChallenge, Techstars, and Keihanna KGAP+, and was named a Top 8 Startup shaping the future of urology by the American Urological Association.Founded in 2023, Swiss-American startup illumicell AI is transforming how clinicians analyze the most fundamental unit of health: the cell in fluid.